drugset / Trial / NCT01048203
A Single Dose Metabolism and Mass Balance Study of 14C-ABR-215050 in Healthy Subjects
NaSingle-groupOpen-label
Summary
This is a single site, open label, single dose, non-randomized study in healthy male and female subjects. The subjects will be evaluated for plasma, urine and feces levels of 14C-ABR-215050 during 21 days.
Timeline
- Start
- 2009-01
- Primary completion
- 2009-03
- Completion
- 2009-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Tasquinimod | Small molecule | 1 mg | Oral |
Indications
No indication recorded.